A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...

Dance Moms’ Paige Hyland shared that she’s found a painful lump on her breast amid her mom Kelly Hyland’s battle with breast ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

An Australian woman’s alarming discovery that a seemingly harmless “pimple” on her forehead was actually cancer has reignited ... turned out to be basal cell carcinoma (BCC).

Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823) Sixteen patients were treated, with a median of four ...

Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory of Advanced Negative Carbon Technologies, Soochow University, Suzhou 215123, China ...